Core Scientific, Inc./tx (CORZ): debt financing — Core Scientific increases credit facility to $1.0B with additional $500M from JPMorgan

Core Scientific, Inc./tx

Total commitments under facility now $1.0B, up from $500M previously from Morgan Stanley.
Additional $500M commitment from JPMorgan Chase N.A.; borrowings bear SOFR + 250 bps.
Proceeds to be used for data center development, including equipment, pre-development costs, property acquisition, and energy procurement.
CEO Adam Sullivan said the expanded facility positions the company to execute on development and go-to-market strategy.
Facility is a 364-day credit agreement; incremental amendment closed March 18, 2026.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Core Scientific, Inc./tx incurred credit facility of $500.0 million incremental commitment with JPMorgan Chase Bank, N.A..

Instrument: credit facility
Principal: $500.0 million incremental commitment
Counterparty: JPMorgan Chase Bank, N.A.
Event: incurrence

Exact text from the filing

On March 18, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement (the “Incremental Amendment”), by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A. (“JPM”), as amendment no. 1 term lender, which amends the Company’s existing credit agreement (the “Initial Credit Agreement”) with the lenders party thereto from time to time and the Agent to increase the term loan commitments thereunder by $500.0 million, to $1.0 billion total, pursuant to the accordion feature of the Initial Credit Agreement. The Company borrowed the full $500.0 incremental commitment on the Closing Date.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Core Scientific, Inc./tx amended Amendment No. 1 to Delayed-Draw Bridge Credit Agreement with Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A. valued at $500.0 million (effective 2026-03-18).

Action: amendment
Agreement: credit facility
Counterparty: Morgan Stanley Senior Funding, Inc. and JPMorgan Chase Bank, N.A.
Value: $500.0 million
Effective: 2026-03-18

Exact text from the filing

On March 18, 2026 (the “Closing Date”), Core Scientific, Inc. (the “Company”) entered into Amendment No. 1 to Delayed-Draw Bridge Credit Agreement (the “Incremental Amendment”), by and among the Company, as borrower, Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent (in such capacity, the “Agent”), and JPMorgan Chase Bank, N.A. (“JPM”), as amendment no. 1 term lender, which amends the Company’s existing credit agreement (the “Initial Credit Agreement”) with the lenders party thereto from time to time and the Agent to increase the term loan commitments thereunder by $500.0 million, to $1.0 billion total, pursuant to the accordion feature of the Initial Credit Agreement.

View on SEC.gov

101 debt financings filed in the last 30 days. Browse all debt financings →

Core Scientific, Inc./tx filing history →

Source: SEC EDGAR

accession 0001628280-26-020327

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.